Genetic Architecture of Coronary Artery Disease in the Genome-Wide Era: Implications for the Emerging “Golden Dozen” Loci

 

 Buy Article Permissions and Reprints

ABSTRACT

Clinicians are well aware of family history as a risk factor for coronary artery disease (CAD) and myocardial infarction (MI). The underlying genetic architecture of CAD/MI is extremely complex and still poorly understood. Overall, the genetic heritability of CAD/MI is estimated to be near 40 to 60%. This proportion includes mainly genes that regulate known risk factors (e.g., lipid metabolism) but also genes involved in as yet unknown metabolic pathways. In the last 2 years, the systematic application of genome-wide association studies in the setting of large collaborative consortia including thousands of patients and controls has led to the identification of several new loci associated with CAD/MI. Here we review current knowledge on the emerging “top” 12 loci, that is, those showing the most consistent associations with clinical phenotypes. Although these genetic variants have little or no current predictive value of at the level of individual patients, they have the potential to disclose novel biological mechanisms involved in the pathophysiology of CAD/MI.

REFERENCES

• 1 Rosamond W, Flegal K, Furie K for the American Heart Association Statistics Committee and Stroke Statistics Subcommittee et al,. Heart disease and stroke statistics—2008 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee.  Circulation. 2008;  117(4) e25-e146
  CrossrefPubMedGoogle Scholar
• 2 Reddy K S. Cardiovascular disease in non-Western countries.  N Engl J Med. 2004;  350(24) 2438-2440
  CrossrefPubMedGoogle Scholar
• 3 Rosenzweig A. Scanning the genome for coronary risk.  N Engl J Med. 2007;  357(5) 497-499
  CrossrefPubMedGoogle Scholar
• 4 Hawe E, Talmud P J, Miller G J, Humphries S E. Second Northwick Park Heart Study . Family history is a coronary heart disease risk factor in the Second Northwick Park Heart Study.  Ann Hum Genet. 2003;  67(Pt 2) 97-106
  CrossrefPubMedGoogle Scholar
• 5 Lloyd-Jones D M, Nam B H, D'Agostino Sr R B et al.. Parental cardiovascular disease as a risk factor for cardiovascular disease in middle-aged adults: a prospective study of parents and offspring.  JAMA. 2004;  291(18) 2204-2211
  CrossrefPubMedGoogle Scholar
• 6 Assmann G, Cullen P, Schulte H. Simple scoring scheme for calculating the risk of acute coronary events based on the 10-year follow-up of the prospective cardiovascular Münster (PROCAM) study.  Circulation. 2002;  105(3) 310-315
  CrossrefPubMedGoogle Scholar
• 7 Yusuf S, Hawken S, Ounpuu S INTERHEART Study Investigators et al. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study.  Lancet. 2004;  364(9438) 937-952
  CrossrefPubMedGoogle Scholar
• 8 Martin N, Boomsma D, Machin G. A twin-pronged attack on complex traits.  Nat Genet. 1997;  17(4) 387-392
  CrossrefPubMedGoogle Scholar
• 9 Marenberg M E, Risch N, Berkman L F, Floderus B, de Faire U. Genetic susceptibility to death from coronary heart disease in a study of twins.  N Engl J Med. 1994;  330(15) 1041-1046
  CrossrefPubMedGoogle Scholar
• 10 Zdravkovic S, Wienke A, Pedersen N L, Marenberg M E, Yashin A I, De Faire U. Heritability of death from coronary heart disease: a 36-year follow-up of 20 966 Swedish twins.  J Intern Med. 2002;  252(3) 247-254
  CrossrefPubMedGoogle Scholar
• 11 Kaluza G, Abukhalil J M, Raizner A E. Identical atheroscler-zotic lesions in identical twins.  Circulation. 2000;  101(4) E63-E64
  PubMedGoogle Scholar
• 12 Motulsky A G, Brunzell J D. Genetics of coronary artery disease. In: King RA, Rotter JI, Motulsky AG The Genetic Basis of Common Disease. 2nd ed. New York, NY; Oxford University Press 2002: 105-125
  PubMedGoogle Scholar
• 13 Watkins H, Farrall M. Genetic susceptibility to coronary artery disease: from promise to progress.  Nat Rev Genet. 2006;  7(3) 163-173
  PubMedGoogle Scholar
• 14 Girelli D, Martinelli N. Genetic scoring and cardiovascular risk. Building a cathedral.  Available at: http://www.athero.org/commentaries/comm768.asp Accessed October 6, 2009; 
  PubMedGoogle Scholar
• 15 Lusis A J. Atherosclerosis.  Nature. 2000;  407(6801) 233-241
  CrossrefPubMedGoogle Scholar
• 16 Roy H, Bhardwaj S, Yla-Herttuala S. Molecular genetics of atherosclerosis.  Hum Genet. 2009;  125(5-6) 467-491
  CrossrefPubMedGoogle Scholar
• 17 Manolio T A, Brooks L D, Collins F S. A HapMap harvest of insights into the genetics of common disease.  J Clin Invest. 2008;  118(5) 1590-1605
  Google Scholar
• 18 Lohmueller K E, Pearce C L, Pike M, Lander E S, Hirschhorn J N. Meta-analysis of genetic association studies supports a contribution of common variants to susceptibility to common disease.  Nat Genet. 2003;  33(2) 177-182
  CrossrefPubMedGoogle Scholar
• 19 Kullo I J, Ding K. Mechanisms of disease: the genetic basis of coronary heart disease.  Nat Clin Pract Cardiovasc Med. 2007;  4(10) 558-569
  CrossrefPubMedGoogle Scholar
• 20 Atherosclerosis, Thrombosis, and Vascular Biology Italian Study Group . No evidence of association between prothrombotic gene polymorphisms and the development of acute myocardial infarction at a young age.  Circulation. 2003;  107(8) 1117-1122
  CrossrefPubMedGoogle Scholar
• 21 Girelli D, Friso S, Trabetti E et al.. Methylenetetrahydrofolate reductase C677T mutation, plasma homocysteine, and folate in subjects from northern Italy with or without angiographically documented severe coronary atherosclerotic disease: evidence for an important genetic-environmental interaction.  Blood. 1998;  91(11) 4158-4163
  PubMedGoogle Scholar
• 22 Girelli D, Russo C, Ferraresi P et al.. Polymorphisms in the factor VII gene and the risk of myocardial infarction in patients with coronary artery disease.  N Engl J Med. 2000;  343(11) 774-780
  CrossrefPubMedGoogle Scholar
• 23 Murata M, Kawano K, Matsubara Y, Ishikawa K, Watanabe K, Ikeda Y. Genetic polymorphisms and risk of coronary artery disease.  Semin Thromb Hemost. 1998;  24(3) 245-250
  Article in Thieme ConnectPubMedGoogle Scholar
• 24 Pare G, Serre D, Brisson D et al.. Genetic analysis of 103 candidate genes for coronary artery disease and associated phenotypes in a founder population reveals a new association between endothelin-1 and high-density lipoprotein cholesterol.  Am J Hum Genet. 2007;  80 673-682
  CrossrefPubMedGoogle Scholar
• 25 Morgan T M, Krumholz H M, Lifton R P, Spertus J A. Nonvalidation of reported genetic risk factors for acute coronary syndrome in a large-scale replication study.  JAMA. 2007;  297(14) 1551-1561
  CrossrefPubMedGoogle Scholar
• 26 Bennet A M, Di Angelantonio E, Ye Z et al.. Association of apolipoprotein E genotypes with lipid levels and coronary risk.  JAMA. 2007;  298(11) 1300-1311
  CrossrefPubMedGoogle Scholar
• 27 Song Y, Stampfer M J, Liu S. Meta-analysis: apolipoprotein E genotypes and risk for coronary heart disease.  Ann Intern Med. 2004;  141(2) 137-147
  PubMedGoogle Scholar
• 28 Ye Z, Liu E HC, Higgins J PT et al.. Seven haemostatic gene polymorphisms in coronary disease: meta-analysis of 66,155 cases and 91,307 controls.  Lancet. 2006;  367(9511) 651-658
  CrossrefPubMedGoogle Scholar
• 29 Arnett D K, Baird A E, Barkley R A American Heart Association Council on Epidemiology and Prevention et al. Relevance of genetics and genomics for prevention and treatment of cardiovascular disease: a scientific statement from the American Heart Association Council on Epidemiology and Prevention, the Stroke Council, and the Functional Genomics and Translational Biology Interdisciplinary Working Group.  Circulation. 2007;  115(22) 2878-2901
  CrossrefPubMedGoogle Scholar
• 30 Boekholdt S M, Kramer M HH. Arterial thrombosis and the role of thrombophilia.  Semin Thromb Hemost. 2007;  33(6) 588-596
  Article in Thieme ConnectPubMedGoogle Scholar
• 31 Ward H, Mitrou P N, Bowman R et al.. APOE genotype, lipids, and coronary heart disease risk: a prospective population study.  Arch Intern Med. 2009;  169(15) 1424-1429
  CrossrefPubMedGoogle Scholar
• 32 Reitsma P H. No praise for folly: genomics will never be useful in arterial thrombosis.  J Thromb Haemost. 2007;  5(3) 454-457
  CrossrefPubMedGoogle Scholar
• 33 International Human Genome Sequencing Consortium . Finishing the euchromatic sequence of the human genome.  Nature. 2004;  431(7011) 931-945
  CrossrefPubMedGoogle Scholar
• 34 International HapMap Consortium . A haplotype map of the human genome.  Nature. 2005;  437(7063) 1299-1320
  CrossrefPubMedGoogle Scholar
• 35 Frazer K A, Ballinger D G, Cox D R International HapMap Consortium et al. A second generation human haplotype map of over 3.1 million SNPs.  Nature. 2007;  449(7164) 851-861
  CrossrefPubMedGoogle Scholar
• 36 Gunderson K L, Steemers F J, Lee G, Mendoza L G, Chee M S. A genome-wide scalable SNP genotyping assay using microarray technology.  Nat Genet. 2005;  37(5) 549-554
  CrossrefPubMedGoogle Scholar
• 37 Steemers F J, Chang W, Lee G, Barker D L, Shen R, Gunderson K L. Whole-genome genotyping with the single-base extension assay.  Nat Methods. 2006;  3(1) 31-33
  CrossrefPubMedGoogle Scholar
• 38 Gresham D, Dunham M J, Botstein D. Comparing whole genomes using DNA microarrays.  Nat Rev Genet. 2008;  9(4) 291-302
  CrossrefPubMedGoogle Scholar
• 39 Hardy J, Singleton A. Genomewide association studies and human disease.  N Engl J Med. 2009;  360(17) 1759-1768
  CrossrefPubMedGoogle Scholar
• 40 Wellcome Trust Case Control Consortium . Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls.  Nature. 2007;  447(7145) 661-678
  CrossrefPubMedGoogle Scholar
• 41 McPherson R, Pertsemlidis A, Kavaslar N et al.. A common allele on chromosome 9 associated with coronary heart disease.  Science. 2007;  316(5830) 1488-1491
  CrossrefPubMedGoogle Scholar
• 42 Helgadottir A, Thorleifsson G, Manolescu A et al.. A common variant on chromosome 9p21 affects the risk of myocardial infarction.  Science. 2007;  316(5830) 1491-1493
  CrossrefPubMedGoogle Scholar
• 43 Samani N J, Erdmann J, Hall A S WTCCC and the Cardiogenics Consortium et al. Genomewide association analysis of coronary artery disease.  N Engl J Med. 2007;  357(5) 443-453
  CrossrefPubMedGoogle Scholar
• 44 Tousoulis D, Briasoulis A, Papageorgiou N, Antoniades C, Stefanadis C. Candidate gene polymorphisms and the 9p21 locus in acute coronary syndromes.  Trends Mol Med. 2008;  14(10) 441-449
  CrossrefPubMedGoogle Scholar
• 45 Schunkert H, Götz A, Braund P Cardiogenics Consortium et al. Repeated replication and a prospective meta-analysis of the association between chromosome 9p21.3 and coronary artery disease.  Circulation. 2008;  117(13) 1675-1684
  CrossrefPubMedGoogle Scholar
• 46 Helgadottir A, Thorleifsson G, Magnusson K P et al.. The same sequence variant on 9p21 associates with myocardial infarction, abdominal aortic aneurysm and intracranial aneurysm.  Nat Genet. 2008;  40(2) 217-224
  CrossrefPubMedGoogle Scholar
• 47 Hannon G J, Beach D. p15INK4B is a potential effector of TGF-beta-induced cell cycle arrest.  Nature. 1994;  371(6494) 257-261
  CrossrefPubMedGoogle Scholar
• 48 Kalinina N, Agrotis A, Antropova Y et al.. Smad expression in human atherosclerotic lesions: evidence for impaired TGF-beta/Smad signaling in smooth muscle cells of fibrofatty lesions.  Arterioscler Thromb Vasc Biol. 2004;  24(8) 1391-1396
  CrossrefPubMedGoogle Scholar
• 49 Schmid M, Sen M, Rosenbach M D, Carrera C J, Friedman H, Carson D A. A methylthioadenosine phosphorylase (MTAP) fusion transcript identifies a new gene on chromosome 9p21 that is frequently deleted in cancer.  Oncogene. 2000;  19(50) 5747-5754
  CrossrefPubMedGoogle Scholar
• 50 Broadbent H M, Peden J F, Lorkowski S PROCARDIS consortium et al. Susceptibility to coronary artery disease and diabetes is encoded by distinct, tightly linked SNPs in the ANRIL locus on chromosome 9p.  Hum Mol Genet. 2008;  17(6) 806-814
  CrossrefPubMedGoogle Scholar
• 51 Lander E S, Linton L M, Birren B et al.. Initial sequencing and analysis of the human genome.  Nature. 2001;  409(6822) 860-921
  CrossrefPubMedGoogle Scholar
• 52 Biémont C, Vieira C. Genetics: junk DNA as an evolutionary force.  Nature. 2006;  443(7111) 521-524
  CrossrefPubMedGoogle Scholar
• 53 Nowacki M, Higgins B P, Maquilan G M, Swart E C, Doak T G, Landweber L F. A functional role for transposases in a large eukaryotic genome.  Science. 2009;  324(5929) 935-938
  CrossrefPubMedGoogle Scholar
• 54 Transcriptomics: rethinking junk DNA.  Nature. 2009;  458(7235) 240-241
  CrossrefPubMedGoogle Scholar
• 55 van Rooij E, Olson E N. MicroRNAs: powerful new regulators of heart disease and provocative therapeutic targets.  J Clin Invest. 2007;  117(9) 2369-2376
  CrossrefPubMedGoogle Scholar
• 56 Mercer T R, Dinger M E, Mattick J S. Long non-coding RNAs: insights into functions.  Nat Rev Genet. 2009;  10(3) 155-159
  CrossrefPubMedGoogle Scholar
• 57 Ponting C P, Oliver P L, Reik W. Evolution and functions of long noncoding RNAs.  Cell. 2009;  136(4) 629-641
  CrossrefPubMedGoogle Scholar
• 58 Amaral P P, Dinger M E, Mercer T R, Mattick J S. The eukaryotic genome as an RNA machine.  Science. 2008;  319(5871) 1787-1789
  CrossrefPubMedGoogle Scholar
• 59 Jarinova O, Stewart A FR, Roberts R et al.. Functional analysis of the chromosome 9p21.3 coronary artery disease risk locus.  Arterioscler Thromb Vasc Biol. 2009;  29 1671-1677
  CrossrefPubMedGoogle Scholar
• 60 Pasmant E, Laurendeau I, Héron D, Vidaud M, Vidaud D, Bièche I. Characterization of a germ-line deletion, including the entire INK4/ARF locus, in a melanoma-neural system tumor family: identification of ANRIL, an antisense noncoding RNA whose expression coclusters with ARF.  Cancer Res. 2007;  67(8) 3963-3969
  CrossrefPubMedGoogle Scholar
• 61 Saxena R, Voight B F, Lyssenko V Diabetes Genetics Initiative of Broad Institute of Harvard and MIT, Lund University, and Novartis Institutes of BioMedical Research et al. Genome-wide association analysis identifies loci for type 2 diabetes and triglyceride levels.  Science. 2007;  316(5829) 1331-1336
  CrossrefPubMedGoogle Scholar
• 62 Zeggini E, Weedon M N, Lindgren C M Wellcome Trust Case Control Consortium (WTCCC) et al. Replication of genome-wide association signals in UK samples reveals risk loci for type 2 diabetes.  Science. 2007;  316(5829) 1336-1341
  CrossrefPubMedGoogle Scholar
• 63 Liu Y, Sanoff H K, Cho H et al.. INK4/ARF transcript expression is associated with chromosome 9p21 variants linked to atherosclerosis.  PLoS One. 2009;  4(4) e5027
  CrossrefPubMedGoogle Scholar
• 64 Brautbar A, Ballantyne C, Lawson K et al.. Impact of adding a single allele in the 9p21 locus to traditional risk factors on risk classification for coronary heart disease and implications for lipid-modifying therapy in the white population of the Atherosclerosis Risk in Communities (ARIC) study.  Circ Cardiovasc Genet. 2009 April 21 (Epub ahead of print); 
  PubMedGoogle Scholar
• 65 Talmud P J, Cooper J A, Palmen J et al.. Chromosome 9p21.3 coronary heart disease locus genotype and prospective risk of CHD in healthy middle-aged men.  Clin Chem. 2008;  54(3) 467-474
  CrossrefPubMedGoogle Scholar
• 66 Paynter N P, Chasman D I, Buring J E, Shiffman D, Cook N R, Ridker P M. Cardiovascular disease risk prediction with and without knowledge of genetic variation at chromosome 9p21.3  Ann Intern Med. 2009;  150(2) 65-72
  CrossrefPubMedGoogle Scholar
• 67 Gulcher J, Stefansson K. Questions about genetic variation in 9p21 as a predictor of cardiovascular risk.  Ann Intern Med. 2009;  150(10) 736
  PubMedGoogle Scholar
• 68 The Myocardial Infarction Genetics Consortium . Genome-wide association of early-onset myocardial infarction with common single nucleotide polymorphisms, common copy number variants, and rare copy number variants.  Nat Genet. 2009;  41 334-341
  CrossrefPubMedGoogle Scholar
• 69 Gudbjartsson D F, Bjornsdottir U S, Halapi E et al.. Sequence variants affecting eosinophil numbers associate with asthma and myocardial infarction.  Nat Genet. 2009;  41(3) 342-347
  CrossrefPubMedGoogle Scholar
• 70 Erdmann J, Grosshennig A, Braund P S et al.. New susceptibility locus for coronary artery disease on chromosome 3q22.3  Nat Genet. 2009;  41(3) 280-282
  CrossrefPubMedGoogle Scholar
• 71 Trégouët D A, König I R, Erdmann J et al.. Genome-wide haplotype association study identifies the SLC22A3-LPAL2-LPA gene cluster as a risk locus for coronary artery disease.  Nat Genet. 2009;  41(3) 283-285
  CrossrefPubMedGoogle Scholar
• 72 Ozaki K, Sato H, Inoue K et al.. SNPs in BRAP associated with risk of myocardial infarction in Asian populations.  Nat Genet. 2009;  41(3) 329-333
  CrossrefPubMedGoogle Scholar
• 73 Samani N J, Deloukas P, Erdmann J Coronary Artery Disease Consortium et al. Large scale association analysis of novel genetic loci for coronary artery disease.  Arterioscler Thromb Vasc Biol. 2009;  29(5) 774-780
  CrossrefPubMedGoogle Scholar
• 74 Kathiresan S, Melander O, Guiducci C et al.. Six new loci associated with blood low-density lipoprotein cholesterol, high-density lipoprotein cholesterol or triglycerides in humans.  Nat Genet. 2008;  40(2) 189-197
  CrossrefPubMedGoogle Scholar
• 75 Willer C J, Sanna S, Jackson A U et al.. Newly identified loci that influence lipid concentrations and risk of coronary artery disease.  Nat Genet. 2008;  40(2) 161-169
  CrossrefPubMedGoogle Scholar
• 76 Sandhu M S, Waterworth D M, Debenham S L et al.. LDL-cholesterol concentrations: a genome-wide association study.  Lancet. 2008;  371(9611) 483-491
  CrossrefPubMedGoogle Scholar
• 77 Wallace C, Newhouse S J, Braund P et al.. Genome-wide association study identifies genes for biomarkers of cardiovascular disease: serum urate and dyslipidemia.  Am J Hum Genet. 2008;  82(1) 139-149
  CrossrefPubMedGoogle Scholar
• 78 Samani N J, Braund P S, Erdmann J et al.. The novel genetic variant predisposing to coronary artery disease in the region of the PSRC1 and CELSR2 genes on chromosome 1 associates with serum cholesterol.  J Mol Med. 2008;  86(11) 1233-1241
  CrossrefPubMedGoogle Scholar
• 79 Shima Y, Copeland N G, Gilbert D J et al.. Differential expression of the seven-pass transmembrane cadherin genes Celsr1-3 and distribution of the Celsr2 protein during mouse development.  Dev Dyn. 2002;  223(3) 321-332
  CrossrefPubMedGoogle Scholar
• 80 Lo P K, Chen J Y, Lo W C et al.. Identification of a novel mouse p53 target gene DDA3.  Oncogene. 1999;  18(54) 7765-7774
  CrossrefPubMedGoogle Scholar
• 81 Nielsen M S, Jacobsen C, Olivecrona G, Gliemann J, Petersen C M. Sortilin/neurotensin receptor-3 binds and mediates degradation of lipoprotein lipase.  J Biol Chem. 1999;  274(13) 8832-8836
  CrossrefPubMedGoogle Scholar
• 82 Linsel-Nitschke P, Heerenb J, Aherrahroua Z et al.. Genetic variation at chromosome 1p13.3 affects sortilin mRNA expression, cellular LDL-uptake and serum LDL levels which translates to the risk of coronary artery disease.  Atherosclerosis. 2009 July 8 (Epub ahead of print); 
  PubMedGoogle Scholar
• 83 Gretarsdottir S, Thorleifsson G, Holm H et al.. The LDL cholesterol and coronary artery disease associated sequence variant on 1p13 also confers risk of abdominal aortic aneurysm and large artery atherosclerotic stroke.  Am J Hum Genet. 2009;  , In press
  PubMedGoogle Scholar
• 84 Danesh J, Collins R, Appleby P, Peto R. Association of fibrinogen, C-reactive protein, albumin, or leukocyte count with coronary heart disease: meta-analyses of prospective studies.  JAMA. 1998;  279(18) 1477-1482
  CrossrefPubMedGoogle Scholar
• 85 Thaulow E, Erikssen J, Sandvik L, Stormorken H, Cohn P F. Blood platelet count and function are related to total and cardiovascular death in apparently healthy men.  Circulation. 1991;  84(2) 613-617
  CrossrefPubMedGoogle Scholar
• 86 Velazquez L, Cheng A M, Fleming H E et al.. Cytokine signaling and hematopoietic homeostasis are disrupted in Lnk-deficient mice.  J Exp Med. 2002;  195(12) 1599-1611
  CrossrefPubMedGoogle Scholar
• 87 Seita J, Ema H, Ooehara J et al.. Lnk negatively regulates self-renewal of hematopoietic stem cells by modifying thrombopoietin-mediated signal transduction.  Proc Natl Acad Sci U S A. 2007;  104(7) 2349-2354
  CrossrefPubMedGoogle Scholar
• 88 Smyth D J, Plagnol V, Walker N M et al.. Shared and distinct genetic variants in type 1 diabetes and celiac disease.  N Engl J Med. 2008;  359(26) 2767-2777
  CrossrefPubMedGoogle Scholar
• 89 Hunt K A, Zhernakova A, Turner G et al.. Newly identified genetic risk variants for celiac disease related to the immune response.  Nat Genet. 2008;  40(4) 395-402
  CrossrefPubMedGoogle Scholar
• 90 Todd J A, Walker N M, Cooper J D et al.. Robust associations of four new chromosome regions from genome-wide analyses of type 1 diabetes.  Nat Genet. 2007;  39(7) 857-864
  CrossrefPubMedGoogle Scholar
• 91 Aiuti A, Webb I J, Bleul C, Springer T, Gutierrez-Ramos J C. The chemokine SDF-1 is a chemoattractant for human CD34+hematopoietic progenitor cells and provides a new mechanism to explain the mobilization of CD34+progenitors to peripheral blood.  J Exp Med. 1997;  185(1) 111-120
  CrossrefPubMedGoogle Scholar
• 92 Askari A T, Unzek S, Popovic Z B et al.. Effect of stromal-cell-derived factor 1 on stem-cell homing and tissue regeneration in ischaemic cardiomyopathy.  Lancet. 2003;  362(9385) 697-703
  CrossrefPubMedGoogle Scholar
• 93 Stellos K, Langer H, Daub K et al.. Platelet-derived stromal cell-derived factor-1 regulates adhesion and promotes differentiation of human CD34+cells to endothelial progenitor cells.  Circulation. 2008;  117(2) 206-215
  CrossrefPubMedGoogle Scholar
• 94 Tillmanns J, Rota M, Hosoda T et al.. Formation of large coronary arteries by cardiac progenitor cells.  Proc Natl Acad Sci U S A. 2008;  105(5) 1668-1673
  CrossrefPubMedGoogle Scholar
• 95 Yoshikawa Y, Satoh T, Tamura T et al.. The M-Ras-RA-GEF-2-Rap1 pathway mediates tumor necrosis factor-α dependent regulation of integrin activation in splenocytes.  Mol Biol Cell. 2007;  18(8) 2949-2959
  CrossrefPubMedGoogle Scholar
• 96 Kamstrup P R, Tybjaerg-Hansen A, Steffensen R, Nordestgaard B G. Genetically elevated lipoprotein(a) and increased risk of myocardial infarction.  JAMA. 2009;  301(22) 2331-2339
  CrossrefPubMedGoogle Scholar
• 97 Hardy J, Singleton A. Genomewide association studies and human disease.  N Engl J Med. 2009;  360(17) 1759-1768
  CrossrefPubMedGoogle Scholar
• 98 Costet P, Krempf M, Cariou B. PCSK9 and LDL cholesterol: unravelling the target to design the bullet.  Trends Biochem Sci. 2008;  33 426-434
  CrossrefPubMedGoogle Scholar
• 99 Kathiresan S, Willer C J, Peloso G M et al.. Common variants at 30 loci contribute to polygenic dyslipidemia.  Nat Genet. 2009;  41(1) 56-65
  CrossrefPubMedGoogle Scholar
• 100 Willer C J, Speliotes E K, Loos R J et al.. Six new loci associated with body mass index highlight a neuronal influence on body weight regulation.  Nat Genet. 2009;  41(1) 25-34
  CrossrefPubMedGoogle Scholar
• 101 Newton-Cheh C, Johnson T, Gateva T et al.. Genome-wide association study identifies eight loci associated with blood pressure.  Nat Genet. 2009 May 10 (Epub ahead of print); 
  PubMedGoogle Scholar
• 102 Kathiresan S, Melander O, Anevski D et al.. Polymorphisms associated with cholesterol and risk of cardiovascular events.  N Engl J Med. 2008;  358(12) 1240-1249
  CrossrefPubMedGoogle Scholar
• 103 Martinelli N, Trabetti E, Pinotti M et al.. Combined effect of hemostatic gene polymorphisms and the risk of myocardial infarction in patients with advanced coronary atherosclerosis.  PLoS One. 2008;  6(3) e1523
  PubMedGoogle Scholar
• 104 Cardon L R, Bell J I. Association study designs for complex diseases.  Nat Rev Genet. 2001;  2(2) 91-99
  CrossrefPubMedGoogle Scholar
• 105 Redon R, Ishikawa S, Fitch K R et al.. Global variation in copy number in the human genome.  Nature. 2006;  444(7118) 444-454
  Google Scholar
• 106 International Schizophrenia Consortium . Rare chromosomal deletions and duplications increase risk of schizophrenia.  Nature. 2008;  455(7210) 237-241
  CrossrefPubMedGoogle Scholar
• 107 Chiang D Y, Getz G, Jaffe D B et al.. High-resolution mapping of copy-number alterations with massively parallel sequencing.  Nat Methods. 2009;  6(1) 99-103
  CrossrefPubMedGoogle Scholar
• 108 Ouwehand W H. Bloodomics and Cardiogenics Consortia . The discovery of genes implicated in myocardial infarction.  J Thromb Haemost. 2009;  7(Suppl 1) 305-307
  CrossrefPubMedGoogle Scholar
• 109 Cohen J C, Kiss R S, Pertsemlidis A, Marcel Y L, McPherson R, Hobbs H H. Multiple rare alleles contribute to low plasma levels of HDL cholesterol.  Science. 2004;  305(5685) 869-872
  CrossrefPubMedGoogle Scholar
• 110 Biesecker L G, Mulliking J C, Facio F M. The ClinSeq Project: piloting large-scale genome sequencing for research in genomic medicine.  Genome Res. 2009 August 5 (Epub ahead of print); 
  PubMedGoogle Scholar
• 111 Eisenstein M. Sequencing in a flash.  Nat Methods. 2009;  6 114-115
  PubMedGoogle Scholar
• 112 Hirschhorn J N. Genomewide association studies—illuminating biologic pathways.  N Engl J Med. 2009;  360(17) 1699-1701
  CrossrefPubMedGoogle Scholar
• 113 Goldstein D B. Common genetic variation and human traits.  N Engl J Med. 2009;  360(17) 1696-1698
  CrossrefPubMedGoogle Scholar
• 114 Hamsten A, Eriksson P. Identifying the susceptibility genes for coronary artery disease: from hyperbole through doubt to cautious optimism.  J Intern Med. 2008;  263(5) 538-552
  CrossrefPubMedGoogle Scholar

Domenico GirelliM.D. Ph.D. 

Department of Clinical and Experimental Medicine, Section of Internal Medicine, University of Verona

Policlinico G.B. Rossi 37134, Verona, Italy

Email: domenico.girelli@univr.it